SSAnkang Health
English Español Português العربية
Consult Now
Home Services Hospitals Doctors Treatment & Verification Patient Stories Resources About FAQ Consult Now
EN ES PT AR
Home / Services / Cardiology & Heart Surgery / Coronary Artery Disease
Cardiology & Heart Surgery

Coronary Artery Disease

Beijing Fuwai Hospital alone performs 16,000+ cardiac surgeries yearly. CABG and PCI outcomes match Cleveland Clinic.

2
Treatment Options
5
Recommended Centers
$5,000
Starting From
7-21 days
Typical Wait

Treatment Plans for Coronary Artery Disease

Compare evidence-based options at top Chinese hospitals — transparent pricing, typical wait, and recovery time.

Percutaneous Coronary Intervention (Drug-Eluting Stent)

Catheter-based stent placement — same-day or overnight stay.

Wait Time
3-5 days
Hospital Stay
1-2 days
Recovery
1-2 weeks
Estimated Price
Approx. $6,500
View Detailed Introduction — Procedure, Price Comparison & More
Price Comparison: China vs. USA
🇨🇳 China
$5,000
🇺🇸 USA
$22,500+
Save up to $17,500 per treatment
Procedure Steps
1
Pre-op: troponin + ECG + coronary angiography
2
Local anesthesia at radial/femoral puncture site
3
Guide catheter advancement to coronary ostium
4
Lesion crossed with guidewire
5
Pre-dilation with semi-compliant balloon
6
Drug-eluting stent deployment at optimal pressure
7
Post-dilation with non-compliant balloon (if needed)
8
Final angiography + IVUS/OCT optimization

What is PCI with Drug-Eluting Stent?

Percutaneous coronary intervention opens blocked coronary arteries using a balloon catheter and implants a drug-coated stent to prevent re-narrowing. It is the standard treatment for acute coronary syndrome and symptomatic stable angina.

Why China?

  • Domestic DES: Chinese-made drug-eluting stents (Firebird, EXCEL) at 1/3 imported Abbott/Medtronic cost
  • Cost: $5,000-$9,000 vs. $25,000-$45,000 in the US per procedure
  • Radial-first approach: Chinese interventionalists lead globally in transradial PCI

Who is a candidate?

  • Acute coronary syndrome (STEMI/NSTEMI)
  • Stable angina with significant stenosis (>70%)
  • 1-2 vessel disease or focal 3-vessel disease

Outcomes

Procedural success rate: >98%. 1-year MACE rate: 5-8%. Target lesion revascularization: <3% with latest-generation DES.

Book Free Consultation WhatsApp

Prices are indicative ranges in USD based on partner hospital published rates. Final quote depends on your medical records and selected hospital — request a free personalized estimate.

Why China for Coronary Artery Disease

Top surgeons individually perform 500+ CABG/year. Drug-eluting stent cost ~1/3 of US.

Recommended Hospitals for Coronary Artery Disease

Hand-picked by case volume, outcomes, and international patient experience.

#1
Fuwai Hospital, CAMS
Beijing

Fuwai Hospital, CAMS

JCI ISO 9001 HIMSS Stage 6
1,400
View Hospital
#2
Beijing Anzhen Hospital
Beijing

Beijing Anzhen Hospital

JCI ISO 9001
1,500
View Hospital
#3
Zhongshan Hospital, Fudan University
Shanghai

Zhongshan Hospital, Fudan University

JCI HIMSS Stage 7 ISO 9001
2,400
View Hospital
#4
Ruijin Hospital, Shanghai Jiao Tong University
Shanghai

Ruijin Hospital, Shanghai Jiao Tong University

JCI ISO 9001 HIMSS Stage 6
2,200
View Hospital
#5
Wuhan Union Hospital, Huazhong University
Wuhan

Wuhan Union Hospital, Huazhong University

JCI ISO 9001
5,000
View Hospital

About Coronary Artery Disease

Common Symptoms
  • Chest pain (angina)
  • Shortness of breath
  • Fatigue on exertion
  • Diaphoresis
  • Radiating arm/jaw pain
Common Causes
  • Hyperlipidemia
  • Hypertension
  • Diabetes
  • Smoking
  • Family history
Diagnostic Methods
  • Coronary CTA
  • Stress echocardiogram
  • Coronary angiography
  • FFR/iFR

Evidence & Reference Standards

Our cardiac care protocols align with major international cardiology societies:

AHA · American Heart Association
Clinical Practice Guidelines
Class I/IIa recommendations for ACS, heart failure, valvular and structural heart disease — applied to every cardiac plan we coordinate.
ACC · American College of Cardiology
Guidelines & Quality Standards
Risk-stratification and procedural appropriateness criteria that frame our pre-op assessment and revascularization decisions.
ESC · European Society of Cardiology
ESC Clinical Practice Guidelines
European reference for STEMI/NSTEMI, AF management and structural intervention — used to cross-check Chinese-hospital cath-lab protocols.
Comparator · Reference
Cleveland Clinic Heart & Vascular Institute
Top-ranked U.S. cardiac programme; our partner hospitals match procedural volume and outcomes at substantially lower cost via JCI-accredited tertiary centres.

SSAnkang Health is a medical-tourism coordination service; clinical procedures are performed by JCI-accredited Chinese hospitals. This page is for general information and does not constitute medical advice.

Related Conditions

Mitral Regurgitation
Robotic mitral valve repair and MitraClip transcatheter edge-to-edge repair wide…
Aortic Valve Stenosis
TAVR / TAVI minimally invasive valve replacement available at Fuwai, Zhongshan, …
Atrial Fibrillation
Cryoballoon and pulsed-field ablation (PFA) catheter ablation for AFib widely of…
Congenital Heart Defects
World-leading paediatric cardiac surgery volume — Anzhen and Fuwai operate 5,000…